<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">problendo</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы Эндокринологии</journal-title><trans-title-group xml:lang="en"><trans-title>Problems of Endocrinology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0375-9660</issn><issn pub-type="epub">2308-1430</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/probl8706</article-id><article-id custom-type="elpub" pub-id-type="custom">problendo-8706</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клинические случаи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Case Reports</subject></subj-group></article-categories><title-group><article-title>Семейный случай нормосмического гипогонадотропного гипогонадизма в сочетании с полидактилией, ассоциированный с дефектом гена FGFR1</article-title><trans-title-group xml:lang="en"><trans-title>Familial case of normosmic hypogonadotropic hypogonadism with polydactyly, associated with defect of FGFR1 gene</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1599-6632</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Герасимова</surname><given-names>Мария Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Gerasimova</surname><given-names>Maria V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант отделения наследственных эндокринопатий</p></bio><bio xml:lang="en"><p>MD</p></bio><email xlink:type="simple">keiden1988@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2000-7694</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Калинченко</surname><given-names>Наталья Юрьевна</given-names></name><name name-style="western" xml:lang="en"><surname>Kalinchenko</surname><given-names>Natalya U.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, ведущий научный сотрудник отделения тиреоидологии, детского соматического и полового развития</p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">kalinnat@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3780-3758</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильев</surname><given-names>Евгений Витальевич</given-names></name><name name-style="western" xml:lang="en"><surname>Vasiliev</surname><given-names>Evgeniy V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат биологических наук, старший научный сотрудник лаборатории отделения наследственных эндокринопатий</p></bio><bio xml:lang="en"><p>PhD</p></bio><email xlink:type="simple">vas-evg@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0520-9132</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петров</surname><given-names>Василий Михайлович</given-names></name><name name-style="western" xml:lang="en"><surname>Petrov</surname><given-names>Vasiliy M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат химических наук, старший научный сотрудник лаборатории отделения </p></bio><bio xml:lang="en"><p>PhD</p></bio><email xlink:type="simple">petrov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8500-4841</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тюльпаков</surname><given-names>Анатолий Николаевич</given-names></name><name name-style="western" xml:lang="en"><surname>Tiulpakov</surname><given-names>Anatoly N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, заведующий лаборатории и отделением наследственных эндокринопатий </p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">anatolytiulpakov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>&lt;p&gt;ФГБУ &amp;laquo;Национальный медицинский исследовательский центр эндокринологии&amp;raquo; Минздрава России&lt;/p&gt;</institution><country>Россия</country></aff><aff xml:lang="en"><institution>&lt;p&gt;Endocrinology Research Centre&lt;/p&gt;</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>09</day><month>04</month><year>2018</year></pub-date><volume>64</volume><issue>1</issue><fpage>38</fpage><lpage>41</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Герасимова М.В., Калинченко Н.Ю., Васильев Е.В., Петров В.М., Тюльпаков А.Н., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Герасимова М.В., Калинченко Н.Ю., Васильев Е.В., Петров В.М., Тюльпаков А.Н.</copyright-holder><copyright-holder xml:lang="en">Gerasimova M.V., Kalinchenko N.U., Vasiliev E.V., Petrov V.M., Tiulpakov A.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.probl-endojournals.ru/jour/article/view/8706">https://www.probl-endojournals.ru/jour/article/view/8706</self-uri><abstract><p>Врожденный изолированный гипогонадотропный гипогонадизм — группа преимущественно моногенных заболеваний, связанных с нарушением выработки, секреции и/или действия ГнРГ, приводящих к выраженной задержке или отсутствию пубертата. Для данной группы заболеваний характерна клиническая и генетическая гетерогенность. На сегодняшний день известно порядка 30 генов-кандидатов, ассоциированных с развитием различных форм вторичного гипогонадизма. Верификация формы врожденного гипогонадотропного гипогонадизма возможна лишь с помощью молекулярно-генетической диагностики. Точная диагностика необходима для прогнозирования течения заболевания и выбора корректной тактики ведения пациента. Приводим описание семейного случая нормосмического гипогонадотропного гипогонадизма и позднего пубертата, ассоциированного с дефектом гена FGFR1. Данный случай интересен яркими фенотипическими проявлениями и их высокой концентрацией в родословной пробанда. Также интерес вызывает нетипичный для дефектов в данном гене фенотип. Молекулярно-генетическое исследование проведено методом секвенирования нового поколения с использованием авторской панели праймеров и полупроводникового секвенатора PGM (Ion Torrent). Подтверждение выявленной мутации и исследование родственника пробанда выполнено по методу Сенгера. У обоих пациентов выявлена гетерозиготная мутация в гене FGFR1, ранее описанная при синдроме Кальмана.</p></abstract><trans-abstract xml:lang="en"><p>Congenital isolated hypogonadotropic hypogonadism refers to a group of predominantly monogenic diseases associated with impaired production, secretion, and/or action of the gonadotropin-releasing hormone (GnRH), which leads to a pronounced delay or absence of puberty. Clinical and genetic heterogeneity is typical of this group of diseases. To date, about 30 candidate genes associated with the development of various forms of secondary hypogonadism are known. Congenital hypogonadotropic hypogonadism can be verified only using molecular genetic diagnostics. The correct diagnosis is necessary for predicting the disease course and choosing the proper approach for managing the patient. We describe a familial case of normosmic hypogonadotropic hypogonadism and late puberty associated with a mutation in the FGFR1 gene. The case is interesting because of pronounced phenotypic manifestations and their high concentration in the proband’s family history. Also of interest is the phenotype untypical of mutations in this gene. The molecular genetic study was performed using new generation sequencing with the authors’ panel of primers and a PGM semiconductor sequencer (Ion Torrent). The Sanger method was used to confirm the identified mutation and examine the proband’s relative. In both patients, a heterozygous mutation in the FGFR1 gene, previously described in Kallmann syndrome, was detected.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>нормосмический гипогонадотропный гипогонадизм</kwd><kwd>FGFR1</kwd><kwd>полидактилия</kwd><kwd>поздний пубертат</kwd><kwd>семейный случай</kwd><kwd>клинический случай</kwd><kwd>секвенирование нового поколения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>normosmic hypogonadotropic hypogonadism</kwd><kwd>FGFR1</kwd><kwd>polydactyly</kwd><kwd>delayed puberty</kwd><kwd>familial case</kwd><kwd>case report</kwd><kwd>next-generation sequencing</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при содействии Фонда поддержки и развития филантропии «КАФ».</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ornitz DM, Itoh N. The Fibroblast Growth Factor signaling pathway. Wiley Interdiscip Rev Dev Biol. 2015;4(3):215-266. doi: 10.1002/wdev.176</mixed-citation><mixed-citation xml:lang="en">Ornitz DM, Itoh N. The Fibroblast Growth Factor signaling pathway. Wiley Interdiscip Rev Dev Biol. 2015;4(3):215-266. doi: 10.1002/wdev.176</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Goetz R, Mohammadi M. Exploring mechanisms of FGF signalling through the lens of structural biology. Nat Rev Mol Cell Biol. 2013;14(3):166-180. doi: 10.1038/nrm3528</mixed-citation><mixed-citation xml:lang="en">Goetz R, Mohammadi M. Exploring mechanisms of FGF signalling through the lens of structural biology. Nat Rev Mol Cell Biol. 2013;14(3):166-180. doi: 10.1038/nrm3528</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Goetz R, Dover K, Laezza F, et al. Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels. J Biol Chem. 2009;284(26):17883-17896. doi: 10.1074/jbc.M109.001842</mixed-citation><mixed-citation xml:lang="en">Goetz R, Dover K, Laezza F, et al. Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels. J Biol Chem. 2009;284(26):17883-17896. doi: 10.1074/jbc.M109.001842</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Powers C. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer. 2000;7(3):165-197. doi: 10.1677/erc.0.0070165</mixed-citation><mixed-citation xml:lang="en">Powers C. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer. 2000;7(3):165-197. doi: 10.1677/erc.0.0070165</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol. 2001;2(3):REVIEWS3005. PMC138918</mixed-citation><mixed-citation xml:lang="en">Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol. 2001;2(3):REVIEWS3005. PMC138918</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005;16(2):139-149. doi: 10.1016/j.cytogfr.2005.01.001</mixed-citation><mixed-citation xml:lang="en">Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005;16(2):139-149. doi: 10.1016/j.cytogfr.2005.01.001</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Albuisson J, Pecheux C, Carel JC, et al. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2). Hum Mutat. 2005;25(1):98-99. doi: 10.1002/humu.9298</mixed-citation><mixed-citation xml:lang="en">Albuisson J, Pecheux C, Carel JC, et al. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2). Hum Mutat. 2005;25(1):98-99. doi: 10.1002/humu.9298</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dode C, Levilliers J, Dupont JM, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet. 2003;33(4):463-465. doi: 10.1038/ng1122</mixed-citation><mixed-citation xml:lang="en">Dode C, Levilliers J, Dupont JM, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet. 2003;33(4):463-465. doi: 10.1038/ng1122</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Pitteloud N, Acierno JS, Jr., Meysing A, et al. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA. 2006;103(16):6281-6286. doi: 10.1073/pnas.0600962103</mixed-citation><mixed-citation xml:lang="en">Pitteloud N, Acierno JS, Jr., Meysing A, et al. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA. 2006;103(16):6281-6286. doi: 10.1073/pnas.0600962103</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Seminara SB, Beranova M, Oliveira LM, et al. Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations. J Clin Endocrinol Metab. 2000;85(2):556-562. doi: 10.1210/jcem.85.2.6357</mixed-citation><mixed-citation xml:lang="en">Seminara SB, Beranova M, Oliveira LM, et al. Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations. J Clin Endocrinol Metab. 2000;85(2):556-562. doi: 10.1210/jcem.85.2.6357</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Pitteloud N, Quinton R, Pearce S, et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest. 2007;117(2):457-463. doi: 10.1172/JCI29884</mixed-citation><mixed-citation xml:lang="en">Pitteloud N, Quinton R, Pearce S, et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest. 2007;117(2):457-463. doi: 10.1172/JCI29884</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Raivio T, Sidis Y, Plummer L, et al. Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2009;94(11):4380-4390. doi: 10.1210/jc.2009-0179</mixed-citation><mixed-citation xml:lang="en">Raivio T, Sidis Y, Plummer L, et al. Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2009;94(11):4380-4390. doi: 10.1210/jc.2009-0179</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff. Fibroblast growth factor receptor 1 [Internet]. http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FGFR1</mixed-citation><mixed-citation xml:lang="en">The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff. Fibroblast growth factor receptor 1 [Internet]. http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FGFR1</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Online Mendelian Inheritance in Man. Fibroblast growth factor receptor 1; FGFR1 [Internet]. http://omim.org/entry/136350?search=FGFR1&amp;highlight=fgfr1</mixed-citation><mixed-citation xml:lang="en">Online Mendelian Inheritance in Man. Fibroblast growth factor receptor 1; FGFR1 [Internet]. http://omim.org/entry/136350?search=FGFR1&amp;highlight=fgfr1</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
